삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

영상의학과 이호연 교수

진료분야
흉부영상의학, 폐결절생검
진료일정 03 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
진료일정 04 月
날짜
토
01
일
02
월
03
화
04
수
05
목
06
금
07
토
08
일
09
월
10
화
11
수
12
목
13
금
14
토
15
일
16
월
17
화
18
수
19
목
20
금
21
토
22
일
23
월
24
화
25
수
26
목
27
금
28
토
29
일
30
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2012.02 서울대학교 대학원 의학 박사
2007.02 서울대학교 대학원 의학 석사
2001.02 한양대학교 의학 학사

경력

경력
2023.03 ~현재 성균관대학교 의과대학 삼성서울병원 영상의학과 교수
2017.03 ~ 2023.02 성균관대학교 의과대학 삼성서울병원 영상의학과 부교수
2013.03 ~ 2017.02 성균관대학교 의과대학 삼성서울병원 영상의학과 조교수
2015.09 ~ 2016.08 일본 Kobe University Hospital 연수
2013.11 정보의학인증의
2009.09 ~ 2013.02 삼성서울병원 영상의학과 임상조교수
2008.09 ~ 2009.08 콜로라도 덴버 National Jewish Medical and Research Center 연수
2008.03 ~ 2008.08 삼성서울병원 영상의학과 임상강사 (흉부 영상의학)
2007.03 ~ 2008.02 서울대학교병원 영상의학과 임상강사 (흉부 영상의학)
2003.03 ~ 2007.02 서울대학교병원 영상의학과 전공의 과정 수료
2006.07 ~ 2006.08 뉴욕 New York-Presbyterian Hospital 연수
2001.03 ~ 2002.02 한양대학교병원 인턴과정 수료

학회활동

학회활동
Korean workshop for pulmonary functional imaging (KWPFI), Chair of Committee on Planning
IASLC, Staging and Prognostic Factors Committee (SPFC), member
Fleishchner Society, member
The Radiological Society of North America (RSNA)
The Korean Society of Medical Informatics
International Society for Magnetic Resonance in Medicine (ISMRM)
Korean Society of magnetic Resonance in Medicine
International Association for the Study of Lung Cancer
Korean Association for the Study of Lung Cancer
Korean Society of Thoracic Radiology, Chair of committee on International Liaison
Korean Radiological Society

수상이력

수상이력
2020.09 대한영상의학회, KSR-태준영상의학상
2018.09 대한영상의학회, KSR-연구영향력 대상
2017.12 대한흉부영상의학회 학술상
2014.12 한국과학기술한림원, 한림선도과학자 선정
2014.12 대한흉부영상의학회 학술상
2014.12 대한폐암학회 학술상
2013.11 Herbert M. Stauffer Award for Best Clinical Paper, Association of University Radiologists
2012.12 대한흉부영상의학회 학술상
2012.12 98th RSNA(북미방사선의학회), Certificate of Merit
2011.12 97th RSNA(북미방사선의학회), Certificate of Merit
2010.12 대한흉부영상의학회 학술상
2010.06 American Society of Clinical Oncology(ASCO), Cancer Foundation Merit Award
2009.12 95th RSNA(북미방사선의학회), Certificate of Merit
2008.12 94th RSNA(북미방사선의학회), Certificate of Merit
2008.12 대한초음파의학회 국제저술상
2007.12 대한흉부영상의학회 학술상
2007.10 대한영상의학회 제63차 학술대회 Best Scientific Paper Award 우수상
2007.02 서울대학교병원 전공의 우수논문 표창
2006.10 11th WFUMB(세계초음파의학회) Young Investigator Award for Scientific Exhibition
2006.02 서울대학교병원 전공의 우수논문 표창
2001.02 한양대학교 의과대학 학장상 수상 (최우등 졸업)
논문
  • CANCERS 2021 10.3390/cancers13112785 Rethinking a Non-Predominant Pattern in Invasive Lung Adenocarcinoma: Prognostic Dissection Focusing on a High-Grade Pattern Choi1, Y; Kim, J; Park, H; Kim, HK; Kim, J; Jeong, JY; Ahn, JH; Lee, HY
    View PubMed
  • DIAGNOSTICS 2021 10.3390/diagnostics11061047 A Cascaded Neural Network for Staging in Non-Small Cell Lung Cancer Using Pre-Treatment CT Choi1, J; Cho, HH; Kwon, J; Lee, HY; Park, H
    View PubMed
  • KOREAN J RADIOL 2021 10.3348/kjr.2020.0955 Imaging Assessment of Visceral Pleural Surface Invasion by Lung Cancer: Comparison of CT and Contrast-Enhanced Radial T1-Weighted Gradient Echo 3-Tesla MRI Zhang1, Y; Kwon, W; Lee, HY; Ko, SM; Kim, SH; Lee, WY; Yong, SJ; Jung, SH; Byun, CS; Lee, J; Yang, H; Han, J; Ackman, JB
    View PubMed
  • CANCERS 2021 10.3390/cancers13071676 Tumor Margin Contains Prognostic Information: Radiomic Margin Characteristics Analysis in Lung Adenocarcinoma Patients Lee1, G; Park, H; Lee, HY; Ahn, JH; Sohn, I; Lee, SH; Kim, J
    View PubMed
  • CANCER IMAGING 2021 10.1186/s40644-021-00400-y Are radiomics features universally applicable to different organs? Lee1, SH; Cho, HH; Kwon, J; Lee, HY; Park, H
    View PubMed
  • RADIOLOGY 2021 10.1148/radiol.2021203427 Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society Johkoh1, T; Lee, KS; Nishino, M; Travis, WD; Ryu, JH; Lee, HY; Ryerson, CJ; Franquet, T; Bankier, AA; Brown, KK; Goo, JM; Kauczor, HU; Lynch, DA; Nicholson, AG; Richeldi, L; Schaefer-Prokop, CM; Verschakelen, J; Raoof, S; Rubin, GD; Powell, C; Inoue, Y; Hatabu, H
    View PubMed
  • EUR RADIOL 2021 10.1007/s00330-020-07648-1 Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions Lee1, HY; Oh, YL; Park, SY
    View PubMed
  • CANCERS 2020 10.3390/cancers12123564 Computed Tomography Radiomics for Residual Positron Emission Tomography-Computed Tomography Uptake in Lymph Nodes after Treatment Kim1, CH; Park, H; Lee, HY; Ahn, JH; Lee, SH; Sohn, I; Choi, JY; Kim, HK
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9113652 Predicting the Risk of Malignancy of Lung Nodules Diagnosed as Indeterminate on Radial Endobronchial Ultrasound-Guided Biopsy Zo1, S; Woo, SY; Kim, S; Lee, JE; Jeong, BH; Um, SW; Kim, H; Kwon, OJ; Lee, HY; Lee, K
    View PubMed
  • J THORAC DIS 2020 10.21037/jtd-20-1716 Clinicoradiopathological features and prognosis according to genomic alterations in patients with resected lung adenocarcinoma Choi1, Y; Kim, KH; Jeong, BH; Lee, KJ; Kim, H; Kwon, OJ; Kim, J; Choi, YL; Lee, HY; Um, SW
    View PubMed
  • THORAC CANCER 2020 10.1111/1759-7714.13701 Clinical T category for lung cancer staging A pragmatic approach for real-world practice Choi1, Y; Kim, SH; Kim, KH; Choi, Y; Park, SG; Sohn, I; Kim, HS; Um, SW; Lee, HY
    View PubMed
  • THORAC CANCER 2020 10.1111/1759-7714.13632 Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung Incidence, prognostic impact, and prediction based on clinicoradiologic factors Lee1, MA; Kang, J; Lee, HY; Kim, W; Shon, I; Hwang, NY; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM
    View PubMed
  • THORAC CANCER 2020 10.1111/1759-7714.13568 Parallel comparison and combining effect of radiomic and emerging genomic data for prognostic stratification ofnon-small celllung carcinoma patients Kim1, KH; Kim, J; Park, H; Kim, H; Lee, SH; Sohn, I; Lee, HY; Park, WY
    View PubMed
  • THORAC CANCER 2020 10.1111/1759-7714.13580 Prediction of tumor doubling time of lung adenocarcinoma using radiomic margin characteristics Yoon1, HJ; Park, H; Lee, HY; Sohn, I; Ahn, J; Lee, SH
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-019-06581-2 Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma Cho1, HH; Lee, G; Lee, HY; Park, H
    View PubMed
  • PLoS One 2020 10.1371/journal.pone.0231227 Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles Yoon1, HJ; Kang, J; Park, H; Sohn, I; Lee, SH; Lee, HY
    View PubMed
  • KOREAN J RADIOL 2020 10.3348/kjr.2019.0630 Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions Lee1, G; Park, H; Bak, SH; Lee, HY
    View PubMed
  • RESP RES 2020 10.1186/s12931-019-1254-0 Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer Shin1, S; Choi, YS; Jung, JJ; Im, Y; Shin, SH; Kang, D; Cho, JH; Kim, HK; Kim, J; Zo, JI; Shim, YM; Park, K; Ahn, MJ; Ahn, YC; Lee, G; Cho, J; Lee, HY; Park, HY
    View PubMed
  • J Thorac Imag. 2019 Mar;34(2):103-115. Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer: Improvements using Radiomics. Lee G1, Bak SH, Lee HY(corresponding author), Choi JY, Park H, Ohno Y, Nishino M, Edwin J.R. van Beek, Lee KS
    View PubMed
  • J Thorac Oncol. 2019 Jun 10. pii: S1556-0864(19)30454-X. doi: 10.1016/j.jtho.2019.05.033. [Epub ahead of print] Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Kim Y1, Kim CH, Lee HY(co-first author), Lee SH, Kim SH, Lee S, Cha H, Hong S, Kim K, Seo SW, Sun JM, Ahn MJ, Ahn JS, Park K.
    View PubMed
  • Int J Cancer. 2019 Feb 26. Improved Treatment Outcome of Pembrolizumab in Patients with Non-small Cell Lung Cancer and Chronic Obstructive Pulmonary Disease. Shin SH11, Park HY1, Im Y1, Jung HA2, Sun JM2, Ahn JS2, Ahn MJ2, Park K2, Lee HY3, Lee SH2,4.
    View PubMed
  • PLos One. 2019 Apr 18;14(4):e0215303. Correction: Predicting clinical outcome with phenotypic clusters using quantitative CT fibrosis and emphysema features in patients with idiopathic pulmonary fibrosis. Bak SH1, Park HY, Nam JH, Lee HY, Lee JH, Sohn I, Chung MP.
    View PubMed
  • Eur Radiol. 2019 Jan 29(1):468-475. Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma. Kim J1, Ryu SY, Lee SH, Lee HY, Park H.
    View PubMed
  • Radiology. 2019;290:805-806. Does Spectral CT Provide Added Diagnostic Value for Defining Malignant Pleural Disease? Lee KS1, Lee HY.
    View PubMed
  • Korean J Radiol. 2019 May;20(5):854-861. Quantitative Thoracic Magnetic Resonance Criteria for the Differentiation of Cysts from Solid Masses in the Anterior Mediastinum. Hwang EJ1, Paek M, Yoon SH, Kim J, Lee HY, Goo JM, Kim H, Kim H, Ackman JB.
    View PubMed
  • Sci Rep. 2019 Jun 19;9(1):8730. doi: 10.1038/s41598-019-45117-y. Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer. Bak SH1, Park H, Sohn I, Lee SH, Ahn MJ, Lee HY(corresponding author).
    View PubMed
  • Expert Rev Respir Med 2019 10.1080/17476348.2020.1697853 Management of incidental pulmonary nodules: current strategies and future perspectives Kim1, TJ; Kim, CH; Lee, HY; Chung, MJ; Shin, SH; Lee, KJ; Lee, KS
    View PubMed
  • INT J CANCER 2019 10.1002/ijc.32235 Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease Shin1, SH; Park, HY; Im, Y; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, HY; Lee, SH
    View PubMed
  • J THORAC ONCOL 2019 10.1016/j.jtho.2019.05.033 Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Kim1, Y; Kim, CH; Lee, HY; Lee, SH; Kim, HS; Lee, S; Cha, H; Hong, S; Kim, K; Seo, SW; Sun, JM; Ahn, MJ; Ahn, JS; Park, K
    View PubMed
  • MEDICINE 2019 10.1097/MD.0000000000016313 Evaluating the tumor biology of lung adenocarcinoma: A multimodal analysis Kim1, KH; Ryu, SY; Lee, HY; Choi, JY; Kwon, OJ; Kim, HK; Shim, YM
    View PubMed
  • Cancer Imaging 2019 10.1186/s40644-019-0239-z Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer Lee1, SH; Cho, HH; Lee, HY; Park, H
    View PubMed
  • RESP RES 2019 10.1186/s12931-019-1087-x Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer Im1, Y; Park, HY; Shin, S; Shin, SH; Lee, H; Ahn, JH; Sohn, I; Cho, JH; Kim, HK; Zo, JI; Shim, YM; Lee, HY; Kim, J
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-45117-y Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer Bak1, SH; Park, H; Sohn, I; Lee, SH; Ahn, MJ; Lee, HY
    View PubMed
  • KOREAN J RADIOL 2019 10.3348/kjr.2018.0699 Quantitative Thoracic Magnetic Resonance Criteria for the Differentiation of Cysts from Solid Masses in the Anterior Mediastinum Hwang1, EJ; Paek, M; Yoon, SH; Kim, J; Lee, HY; Goo, JM; Kim, H; Kim, H; Ackman, JB
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0215303 Predicting clinical outcome with phenotypic clusters using quantitative CT fibrosis and emphysema features in patients with idiopathic pulmonary fibrosis Bak1, SH; Park, HY; Nam, JH; Lee, HY; Lee, JH; Sohn, I; Chung, MP
    View PubMed
  • RADIOLOGY 2019 10.1148/radiol.2018182768 Does Spectral CT Provide Added Diagnostic Value for Defining Malignant Pleural Disease? Lee1, KS; Lee, HY
    View PubMed
  • J THORAC IMAG 2019 10.1097/RTI.0000000000000390 Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer Improvements Using Radiomics Lee1, G; Bak, SH; Lee, HY; Choi, JY; Park, H; Lee, SH; Ohno, Y; Nishino, M; van Beek, EJR; Lee, KS
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-018-5590-0 Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma Kim1, J; Ryu, SY; Lee, SH; Lee, HY; Park, H
    View PubMed
  • AJR Am J Roentgenol. 2018 Nov;211(5):1026-1034. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics. Kim J1, Choi SJ, Lee SH, Lee HY, Park H
    View PubMed
  • PLoS One. 2018 Jul 31;13(7):e0201242. Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults. Yang B1, Jhun BW, Shin SH, Jeong BH, Um SW, Zo JI, Lee HY, Sohn I, Kim H, Kwon OJ, Lee K
    View PubMed
  • J Thorac Oncol 2018 Aug;13(8):1106-1112. Transient asymptomatic pulmonary opacities during osimertinib treatment and its clinical implication. Lee H1, Lee HY(co-first author), Sun JM, Lee SH, Kim Y, Park SE, Ahn JS, Park K, Ahn MJ
    View PubMed
  • J Biopharm stat. 2018;28(5):927-938. Statistical Methods for Conditional Survival Analysis. Jung SH1, Lee HY, Chow SC.
    View PubMed
  • AJR Am J Roentgenol. 2018 Jun;210(6):1216-1225. Morphologic Characterization of Pulmonary Nodules With Ultrashort TE MRI at 3T. Wielp?tz MO1, Lee HY, Koyama H, Yoshikawa T, Seki S, Kishida Y, Sakai Y, Kauczor HU, Sugimura K, Ohno Y.
    View PubMed
  • Oncologist 2018 Jul;23(7):806-813. Comprehensive CT Radiomic s Analysis of Lung Adenocarcinoma for Prognostication. Lee G1, Park H, Sohn I, See SH, Song SH, Kim H, Lee KS, Shim YM, Lee HY(corresponding author).
    View PubMed
  • Sci Rep 2018 Feb 19;8(1):3284. Imaging genotyping of functional signaling pathways in lung squamous cell lung carcinoma using a radiomics approach. Bak SH1, Park H, Lee HY(corresponding author), Kim Y, Kim HL, Jung SH, Kim H, Kim J, Park K.
    View PubMed
  • J Thorac Dis. 2018 Jan;10(1): 388-397 Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer Kim D1, Kim HK, Kim SH, Lee HY, Cho JH, Choi YS, Kim K, Kim J, Zo JI, Shim YM.
    View PubMed
  • J Pathol Transl Med. 2018 May;52(3):148-156. Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01). Ku BM1, Heo MH, Kim JH, Cho BC, Cho EK, Min YJ, Lee KH, Sun JM, Lee SH, Ahn JS, Park K, Kim TJ, Lee HY, Kim H, Lee KJ, Ahn MJ
    View PubMed
  • Sci Rep. 2018 May 16;8(1):7691. Genomic alterations of ground-glass nodular lung adenocarcinoma Lee H1, Joung JG, Shin HT, Kim DH, Kim Y, Kim H, Kwon OJ, Shim YM, Lee HY, Lee KS, Choi YL, Park WY, Hayes DN, Um SW.
    View PubMed
  • Nucl Med Mol Imaging 2018 Apr;52(2):91-98. CT Radiomics in Thoracic Oncology: Technique and Clinical Applications. Lee G1, Bak SH, Lee HY(corresponding author).
    View PubMed
  • Sci Rep 2018 Jun 12;8(1):8968. Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach Lee SW1, Park H, Lee HY(corresponding author), Sohn I, Lee SH, Kang J, Sun JM, Ahn MJ.
    View PubMed
  • AM J ROENTGENOL 2018 10.2214/AJR.18.19507 Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics Kim1, J; Choi, SJ; Lee, SH; Lee, HY; Park, H
    View PubMed
  • J BIOPHARM STAT 2018 10.1080/10543406.2017.1405012 Statistical Methods for Conditional Survival Analysis Jung1, SH; Lee, HY; Chow, SC
    View PubMed
  • J THORAC ONCOL 2018 10.1016/j.jtho.2018.04.038 Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication Lee1, H; Lee, HY; Sun, JM; Lee, SN; Kim, Y; Park, SE; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0201242 Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults Yang1, B; Jhun, BW; Shin, SH; Jeong, BH; Um, SW; Zo, JI; Lee, HY; Sohn, I; Kim, H; Kwon, OJ; Lee, K
    View PubMed
  • ONCOLOGIST 2018 10.1634/theoncologist.2017-0538 Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication Lee1, G; Park, H; Sohn, I; Lee, SH; Song, SH; Kim, H; Lee, KS; Shim, YM; Lee, HY
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-27273-9 Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach Lee1, SW; Park, H; Lee, HY; Sohn, I; Lee, SH; Kang, J; Sun, JM; Ahn, MJ
    View PubMed
  • AM J ROENTGENOL 2018 10.2214/AJR.17.18961 Morphologic Characterization of Pulmonary Nodules With Ultrashort TE MRI at 3T Wielputz1, MO; Lee, HY; Koyama, H; Yoshikawa, T; Seki, S; Kishida, Y; Sakai, Y; Kauczor, HU; Sugimura, K; Ohno, Y
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-25800-2 Genomic alterations of ground-glass nodular lung adenocarcinoma Lee1, H; Joung, JG; Shin, HT; Kim, DH; Kim, Y; Kim, H; Kwon, OJ; Shim, YM; Lee, HY; Lee, KS; Choi, YL; Park, WY; Hayes, DN; Um, SW
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-21706-1 Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach Bak1, SH; Park, H; Lee, HY; Kim, Y; Kim, HL; Jung, SH; Kim, H; Kim, J; Park, K
    View PubMed
  • Journal of thoracic disease 2018 10.21037/jtd.2017.12.38 Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer Kim1, D; Kim, HK; Kim, SH; Lee, HY; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Shim, YM
    View PubMed
  • Int J Chron Obstruct Pulmon Dis 2017 10.2147/COPD.S146899 Overlaps and uncertainties of smoking-related idiopathic interstitial pneumonias Bak1, SH; Lee, HY
    View PubMed
  • Oncotarget. 2017 May 9;8(19):32201-32211. doi: 10.18632/oncotarget.12920. Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma Kim W11, Lee HY1, Jung SH2, Woo MA2, Kim HK3, Choi YS3, Kim J3, Zo JI3, Shim YM3, Han J4, Jeong JY4,5, Choi JY6, Lee KS1.
    View PubMed
  • J Thorac Oncol. 2017 Apr;12(4):624-632. doi: 10.1016/j.jtho.2016.11.2230. Epub 2016 Dec 5. Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma Song SH11, Park H2, Lee G3, Lee HY4, Sohn I5, Kim HS5, Lee SH6, Jeong JY7, Kim J8, Lee KS1, Shim YM8.
    View PubMed
  • Oncotarget. 2017 Jan 3;8(1):523-535. doi: 10.18632/oncotarget.13476. Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy ct images Bae JM11, Jeong JY2, Lee HY1, Sohn I3, Kim HS3, Son JY1, Kwon OJ4, Choi JY5, Lee KS1, Shim YM6.
    View PubMed
  • Eur J Radiol. 2017 Jan;86:297-307. doi: 10.1016/j.ejrad.2016.09.005. Epub 2016 Sep 10. Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art Lee G11, Lee HY2, Park H3, Schiebler ML4, van Beek EJR5, Ohno Y6, Seo JB7, Leung A8.
    View PubMed
  • J Thorac Dis. 2016 Nov;8(11):3175-3186. doi: 10.21037/jtd.2016.11.25. The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations Cha YK11, Lee HY2, Ahn MJ3, Park K3, Ahn JS3, Sun JM3, Choi YL4, Lee KS2.
    View PubMed
  • Oncotarget. 2016 Oct 11;7(41):67302-67313. doi: 10.18632/oncotarget.11693. Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma Choi ER11, Lee HY1, Jeong JY2, Choi YL3, Kim J4, Bae J1, Lee KS1, Shim YM4.
    View PubMed
  • Oncotarget. 2016 Oct 25;7(43):70353-70363. doi: 10.18632/oncotarget.11857. Pathologic heterogeneity of lung adenocarcinomas: A novel pathologic index predicts survival Lee G11,2, Choi ER1, Lee HY1, Jeong JY3, Ahn JH4, Kim S4, Bae J1, Kim HK5, Choi YS5, Kim J5, Zo J5, Lee KS1, Shim YM5.
    View PubMed
  • Diagn Interv Radiol. 2016 Sep-Oct;22(5):407-21. doi: 10.5152/dir.2016.16123. Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications Ohno Y11, Koyama H, Lee HY, Miura S, Yoshikawa T, Sugimura K.
    View PubMed
  • J Thorac Imaging. 2016 Jul;31(4):215-27. doi: 10.1097/RTI.0000000000000210. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging Ohno Y11, Koyama H, Lee HY, Yoshikawa T, Sugimura K.
    View PubMed
  • J Thorac Oncol. 2016 Jul;11(7):1064-73. doi: 10.1016/j.jtho.2016.03.011. Epub 2016 Mar 22. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas Lee HY11, Cha MJ1, Lee KS2, Lee HY1, Kwon OJ3, Choi JY4, Kim HK5, Choi YS5, Kim J5, Shim YM5.
    View PubMed
  • Radiology. 2016 Jul;280(1):324-6. doi: 10.1148/radiol.2016152476. Management of CT Screening-detected Persistent Nonsolid Pulmonary Nodules: An Asian Perspective Yi CA11, Lee HY1, Kim TJ1, Lee KS1.
    View PubMed
  • CHEST, JUN 2016, 149(6):1587-1588, DOI: 10.1016/j.chest.2016.04.005 Quantitative CT Scanning Analysis of Pure Ground-Glass Opacity Nodules Predicts Further CT Change Response Bak SH1, Lee HY
    View PubMed
  • Eur Radiol. 2016 Jun;26(6):1538-46. doi: 10.1007/s00330-015-4029-0. Epub 2015 Oct 11. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma Song SH11, Ahn JH2, Lee HY3, Lee G4, Choi JY5, Kang J6, Kim EY1, Han J7, Kwon OJ8, Lee KS1, Kim HK9, Choi YS9, Kim J9, Shim YM9.
    View PubMed
  • Eur Radiol. 2016 May;26(5):1368-77. doi: 10.1007/s00330-015-3946-2. Epub 2015 Aug 9. Perfusion- and pattern-based quantitative CT indexes using contrast-enhanced dual-energy computed tomography in diffuse interstitial lung disease: relationships with physiologic impairment and prediction of prognosis Moon JW11, Bae JP2, Lee HY3, Kim N4, Chung MP5, Park HY5, Chang Y2, Seo JB2, Lee KS6.
    View PubMed
  • Diagn Interv Radiol. 2016 May-Jun;22(3):231-40. doi: 10.5152/dir.2015.15171. Perfusion parameters as potential imaging biomarkers for the early prediction of radiotherapy response in a rat tumor model Lee HY11, Kim N, Goo JM, Chie EK, Song HJ.
    View PubMed
  • Medicine (Baltimore). 2016 Mar;95(12):e3109. doi: 10.1097/MD.0000000000003109. Anatomic and Functional Evaluation of Central Lymphatics With Noninvasive Magnetic Resonance Lymphangiography Kim EY11, Hwang HS, Lee HY, Cho JH, Kim HK, Lee KS, Shim YM, Zo J.
    View PubMed
  • Cancer Imaging. 2016 Mar 16;16:5. doi: 10.1186/s40644-016-0063-7. Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study Lee JH11, Lee HY2, Ahn MJ3, Park K3, Ahn JS3, Sun JM3, Lee KS1.
    View PubMed
  • Expert Rev Respir Med. 2016;10(3):261-78. doi: 10.1586/17476348.2016.1141053. Epub 2016 Feb 2. Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules Cha MJ11, Lee KS1, Kim HS1, Lee SW1, Jeong CJ1, Kim EY1, Lee HY1.
    View PubMed
  • Oncotarget. 2016 Feb 9;7(6):6984-93. doi: 10.18632/oncotarget.6874. Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02) Lee JY11, Qing X2, Xiumin W2, Yali B2, Chi S3, Bak SH4, Lee HY5, Sun JM1, Lee SH1, Ahn JS1, Cho EK6, Kim DW7, Kim HR8, Min YJ9, Jung SH3, Park K1, Mao M2, Ahn MJ1.
    View PubMed
  • J Thorac Cardiovasc Surg. 2016 Jan;151(1):280-1. doi: 10.1016/j.jtcvs.2015.10.022. IS PREOPERATIVE POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY A USEFUL DIAGNOSTIC OR STAGING TOOL FOR PURE GROUND GLASS OPACITY NODULAR ADENOCARDINOMAS Reply Cho H11, Lee HY2.
    View PubMed
  • Eur Radiol. 2016 Jan;26(1):43-54. doi: 10.1007/s00330-015-3816-y. Epub 2015 May 17. y Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: the added value of using iodine mapping Son JY11, Lee HY2, Kim JH1, Han J3, Jeong JY3,4, Lee KS1, Kwon OJ5, Shim YM6.
    View PubMed
  • Chest. 2016 Jan;149(1):180-91. doi: 10.1378/chest.15-0034. Epub 2016 Jan 6. Quantitative CT Scanning Analysis of Pure Ground-Glass Opacity Nodules Predicts Further CT Scanning Change Bak SH11, Lee HY2, Kim JH1, Um SW3, Kwon OJ3, Han J4, Kim HK5, Kim J5, Lee KS1.
    View PubMed
  • J Thorac Oncol. 2015 Dec;10(12):1785-94. doi: 10.1097/JTO.0000000000000689. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma Lee HY11, Lee SW, Lee KS, Jeong JY, Choi JY, Kwon OJ, Song SH, Kim EY, Kim J, Shim YM.
    View PubMed
  • Medicine (Baltimore). 2015 Nov;94(44):e1896. doi: 10.1097/MD.0000000000001896. False-positive Uptake on Positron Emission Tomography/Computed Tomography Immediately After Lung Biopsy A Case Report Bae JM11, Lee HY, Choi JY.
    View PubMed
  • Medicine (Baltimore). 2015 Oct;94(41):e1753. doi: 10.1097/MD.0000000000001753. Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach Yoon HJ11, Sohn I, Cho JH, Lee HY, Kim JH, Choi YL, Kim H, Lee G, Lee KS, Kim J.
    View PubMed
  • J Thorac Cardiovasc Surg. 2015 Sep;150(3):514-20. doi: 10.1016/j.jtcvs.2015.06.024. Epub 2015 Jun 18. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary Cho H11, Lee HY2, Kim J3, Kim HK3, Choi JY4, Um SW5, Lee KS1.
    View PubMed
  • KOREAN JOURNAL OF RADIOLOGY, SEP-OCT 2015, 16(5):1166-1170, 10.3348/kjr.2015.16.5.1166 Primary Pulmonary Low-Grade Angiosarcoma Characterized by Mismatch between F-18-FDG PET and Dynamic Contrast-Enhanced CT Kim EY1, Lee HY, Han J, Choi JY,
    View PubMed
  • J Thorac Cardiovasc Surg. 2015 Sep;150(3):514-20. doi: 10.1016/j.jtcvs.2015.06.024. Epub 2015 Jun 18. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary Cho H11, Lee HY2, Kim J3, Kim HK3, Choi JY4, Um SW5, Lee KS1.
    View PubMed
  • Korean J Radiol. 2015 Jul-Aug;16(4):942-6. doi: 10.3348/kjr.2015.16.4.942. Epub 2015 Jul 1. Lung Infarction due to Pulmonary Vein Stenosis after Ablation Therapy for Atrial Fibrillation Misdiagnosed as Organizing Pneumonia: Sequential Changes on CT in Two Cases Kwon MR11, Lee HY1, Cho JH2, Um SW3.
    View PubMed
  • Clin Lung Cancer. 2015 May;16(3):228-36. doi: 10.1016/j.cllc.2014.11.002. Epub 2014 Nov 18. Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy Cha YK11, Lee HY2, Ahn MJ3, Choi YL4, Lee JH1, Park K3, Lee KS1.
    View PubMed
  • Am J Surg Pathol. 2015 May;39(5):660-6. doi: 10.1097/PAS.0000000000000399. Clinical Impact of Minimal Micropapillary Pattern in Invasive Lung Adenocarcinoma Prognostic Significance and Survival Outcomes Lee G11, Lee HY, Jeong JY, Han J, Cha MJ, Lee KS, Kim J, Shim YM.
    View PubMed
  • Chest. 2015 May;147(5):1299-306. doi: 10.1378/chest.14-0717. Change of Junctions Between Stations 10 and 4 in the New International Association for the Study of Lung Cancer Lymph Node Map A Validation Study from a Single, Tertiary Referral Hospital Experience Lee S1, Lee HY, Lee KS, Yie M, Zo J, Shim YM, Han J, Ahn JH.
    View PubMed
  • Ann Thorac Med.?2015 Apr-Jun;10(2):105-11. doi: 10.4103/1817-1737.151441. Chronic obstructive pulmonary disease severity is associated with severe pneumonia Eom JS11,?Song WJ2,?Yoo H2,?Jeong BH2,?Lee HY3,?Koh WJ2,?Jeon K2,?Park HY2.
    View PubMed
  • Cancer Chemother Pharmacol.?2015 Jan;75(1):77-85. doi: 10.1007/s00280-014-2619-1. Epub 2014 Nov 6. Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery Lim HJ11,?Lee HY,?Lee KS,?Han J,?Kwon OJ,?Park K,?Ahn YC,?Kim BT,?Shim YM.
    View PubMed
  • Clin Nucl Med. 2015 Jan;40(1):e34-9. doi: 10.1097/RLU.0000000000000581. Role of Imaging Biomarkers in Predicting Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Jeong CJ11, Lee HY, Han J, Jeong JY, Lee KS, Choi YL, Choi JY.
    View PubMed
  • Cancer Res Treat.?2014 Oct;46(4):393-402. doi: 10.4143/crt.2013.132. Epub 2014 Jul 18. Ultra-Low-Dose Chest CT in Patients with Neutropenic Fever and Hematologic Malignancy: Image Quality and Its Diagnostic Performance Kim HJ11,?Park SY2,?Lee HY1,?Lee KS1,?Shin KE1,?Moon JW1.
    View PubMed
  • Thorac Cardiovasc Surg. 2014 Oct;62(7):616-23. doi: 10.1055/s-0033-1363767. Epub 2014 Apr 20. Approach to Metastasis-Suspected Nodule Accompanying Operable Non-Small Cell Lung Cancer Shin S11, Park JS2, Kim HK1, Choi YS1, Shim YM1, Lee HY3, Kim J1.
    View PubMed
  • J Urol. 2014 Sep;192(3):940-6. doi: 10.1016/j.juro.2014.03.097. Epub 2014 Apr 1. Prognostic Significance of Biallelic Loss of PTEN in Clear Cell Renal Cell Carcinoma Lee HJ11, Lee HY2, Lee JH3, Lee H4, Kang G5, Song JS1, Kang J6, Kim JH7.
    View PubMed
  • Korean J Radiol.?2014 Sep-Oct;15(5):646-50. doi: 10.3348/kjr.2014.15.5.646. Epub 2014 Sep 12. Synchronous Triple Primary Lung Cancers: A Case Report Yoon HJ11,?Lee HY1,?Han J2,?Choi YL2.
    View PubMed
  • PLoS One.?2014 Sep 9;9(9):e107476. doi: 10.1371/journal.pone.0107476. eCollection 2014. The Value of CT for Disease Detection and Prognosis Determination in Combined Pulmonary Fibrosis and Emphysema (CPFE) Choi SH11,?Lee HY1,?Lee KS1,?Chung MP2,?Kwon OJ2,?Han J3,?Kim N4,?Seo JB4.
    View PubMed
  • Quantitative CT Analysis of Pulmonary Ground-Glass Opacity Nodules for the Distinction of Invasive Adenocarcinoma from Pre-Invasive or Minimally Invasive Adenocarcinoma
    View PubMed
  • Reliability of small biopsy or cytology for the diagnosis of pulmonary mucinous adenocarcinoma
    View PubMed
  • World J Gastroenterol. 2014 May 28;20(20):6133-45. doi: 10.3748/wjg.v20.i20.6133. Pulmonary metastasectomy for colorectal cancer: How many nodules, how many times Kim HK11, Cho JH1, Lee HY1, Lee J1, Kim J1.
    View PubMed
  • J Thorac Cardiovasc Surg.?2014 Mar;147(3):921-928.e2. doi: 10.1016/j.jtcvs.2013.09.045. Epub 2013 Nov 4. Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcome Cha MJ11,?Lee HY2,?Lee KS1,?Jeong JY3,?Han J3,?Shim YM4,?Hwang HS1.
    View PubMed
  • AJR Am J Roentgenol.?2014 Mar;202(3):W224-33. doi: 10.2214/AJR.13.11819. Pure Ground-Glass Opacity Neoplastic Lung Nodules: Histopathology, Imaging, and Management Lee HY11,?Choi YL,?Lee KS,?Han J,?Zo JI,?Shim YM,?Moon JW.
    View PubMed
  • Eur Radiol. 2014 Mar;24(3):677-84. doi: 10.1007/s00330-013-3054-0. Epub 2013 Nov 1. Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT Shin KE11, Yi CA, Kim TS, Lee HY, Choi YS, Kim HK, Kim J.
    View PubMed
  • Anticancer Res. 2014 Feb;34(2):707-14. Assessment of Intratumoral Heterogeneity of Oncogenic Driver Mutations in Surgically-resected Lung Adenocarcinoma: Implications of Percutaneous Biopsy-based Molecular Assay for Target-directed Therapy Kim HK11, Lee HY, Choi YL, Choi SJ, Choi H, Lee J, Han J, Ahn MJ, Lee KS, Kim J.
    View PubMed
  • PLoS One.?2014 Feb 26;9(2):e88598. doi: 10.1371/journal.pone.0088598. eCollection 2014. Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy Chong Y11,?Kim JH1,?Lee HY1,?Ahn YC2,?Lee KS1,?Ahn MJ3,?Kim J4,?Shim YM4,?Han J5,?Choi YL5.
    View PubMed
  • Anticancer Res.?2013 Nov;33(11):5127-33. High-throughput Molecular Genotyping for Small Biopsy Samples in Advanced Non-small Cell Lung Cancer Patients Maeng CH11,?Lee HY,?Kim YW,?Choi MK,?Hong JY,?Jung HA,?Lee KS,?Kim H,?Kwon OJ,?Sun JM,?Ahn JS,?Park K,?Um SW,?Ahn MJ.
    View PubMed
  • J Magn Reson?Imaging.?2013 Oct;38(4):905-13. doi: 10.1002/jmri.24080. Epub 2013 Mar 21. Histopathology of Lung Adenocarcinoma Based on New IASLC/ATS/ERS Classification: Prognostic Stratification With Functional and Metabolic Imaging Biomarkers Lee HY11,?Jeong JY,?Lee KS,?Yi CA,?Kim BT,?Kang H,?Kwon OJ,?Shim YM,?Han J.
    View PubMed
  • Clin Rheumatol.?2013 Oct;32(10):1459-65. doi: 10.1007/s10067-013-2304-5. Epub 2013 Jun 2. Imaging manifestations of autoimmune disease-associated lymphoproliferative disorders of the lung Lee G11,?Lee HY,?Lee KS,?Lee KJ,?Cha HS,?Han J,?Chung MP.
    View PubMed
  • Korean J Radiol.?2013 Jul-Aug;14(4):692-6. doi: 10.3348/kjr.2013.14.4.692. Epub 2013 Jul 17. Uncommon of the Uncommon: Malignant Perivascular Epithelioid Cell Tumor of the Lung Lim HJ11,?Lee HY,?Han J,?Choi YS,?Lee KS.
    View PubMed
  • Korean J Radiol.?2013 Mar-Apr;14(2):384-8. doi: 10.3348/kjr.2013.14.2.384. Epub 2013 Feb 22. Pulmonary Mucinous Cystadenocarcinoma: Report a Case and Review of CT Findings Choi YA11,?Lee HY,?Han J,?Choi JY,?Kim J,?Kwon OJ,?Lee KS.
    View PubMed
  • Radiology. 2013 Feb;266(2):626-35. doi: 10.1148/radiol.12120385. Epub 2012 Dec 6. Chronic Obstructive Pulmonary Disease: Lobe-based Visual Assessment of Volumetric CT by Using Standard Images-Comparison with Quantitative CT and Pulmonary Function Test in the COPDGene Study Kim SS11, Seo JB, Lee HY, Nevrekar DV, Forssen AV, Crapo JD, Schroeder JD, Lynch DA.
    View PubMed
  • Radiology.?2012 Dec;265(3):939-48. doi: 10.1148/radiol.12112613. Epub 2012 Aug 28. Repeat Biopsy for Mutational Analysis of Non-Small Cell Lung Cancers Resistant to Previous Chemotherapy: Adequacy and Complications Yoon HJ11,?Lee HY,?Lee KS,?Choi YL,?Ahn MJ,?Park K,?Ahn JS,?Sun JM,?Kim J,?Kim TS,?Chung MJ,?Yi CA.
    View PubMed
  • Korean J Radiol.?2012 Nov-Dec;13(6):702-10. doi: 10.3348/kjr.2012.13.6.702. Epub 2012 Oct 12. Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response Kim YN11,?Lee HY,?Lee KS,?Seo JB,?Chung MJ,?Ahn MJ,?Park K,?Kim TS,?Yi CA.
    View PubMed
  • AJR Am J Roentgenol.?2012 Nov;199(5):982-9. doi: 10.2214/AJR.11.8192. High-Resolution CT Findings in Fibrotic Idiopathic Interstitial Pneumonias With Little Honeycombing: Serial Changes and Prognostic Implications Lee HY11,?Lee KS,?Jeong YJ,?Hwang JH,?Kim HJ,?Chung MP,?Han J.
    View PubMed
  • Radiology.?2012 Sep;264(3):884-93. doi: 10.1148/radiol.12111793. Epub 2012 Jul 24. Solitary Pulmonary Nodular Lung Adenocarcinoma: Correlation of Histopathologic Scoring and Patient Survival with Imaging Biomarkers Lee HY11,?Jeong JY,?Lee KS,?Kim HJ,?Han J,?Kim BT,?Kim J,?Shim YM,?Kim JH,?Song I.
    View PubMed
  • J PEDIATR SURG/ 2012;47:1629 Computed Tomography-Guided Localization of Lung Nodules: Dealing with Initial Mislocalization Jung Won Moon1, Ho Yun Lee, Yong Soo Choi, Kyung Soo Lee
    View PubMed
  • Korean J Radiol.?2012 Jul-Aug;13(4):371-90. doi: 10.3348/kjr.2012.13.4.371. Epub 2012 Jun 18. Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts Kang H11,?Lee HY,?Lee KS,?Kim JH.
    View PubMed
  • J Thorac Cardiovasc Surg.?2012 Apr;143(4):809-14. doi: 10.1016/j.jtcvs.2011.10.038. Epub 2011 Nov 20. Factors determining successful computed tomography-guided localization of lung nodules Seo JM11,?Lee HY,?Kim HK,?Choi YS,?Kim J,?Shim YM,?Lee KS.
    View PubMed
  • Acad Radiol.?2012 Apr;19(4):440-5. doi: 10.1016/j.acra.2011.12.010. Epub 2012 Jan 23. Baseline SUVmax at PET-CT in Stage IIIA Non-small-cell Lung Cancer Patients Undergoing Surgery after Neoadjuvant Therapy: Prognostic Implication Focused on Histopathologic Subtypes Lee HY11,?Lee KS,?Park J,?Han J,?Kim BT,?Kwon OJ,?Ahn YC,?Ahn MJ,?Park K,?Kim J,?Shim YM.
    View PubMed
  • Cancer?Chemother Pharmacol.?2011 Nov;68(5):1099-109. doi: 10.1007/s00280-011-1737-2. Epub 2011 Sep 13. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight Min JH11,?Lee HY,?Lim H,?Ahn MJ,?Park K,?Chung MP,?Lee KS.
    View PubMed
  • Intern Med.?2011;50(24):3027-9. Epub 2011 Dec 15. Tree-In-Bud Sign as a Manifestation of Localized Pulmonary Lymphatic Metastasis from a Pancreas Cancer Moon JW11,?Lee HY,?Han J,?Lee KS.
    View PubMed
  • Lung?Cancer.?2011 Jul;73(1):63-9. doi: 10.1016/j.lungcan.2010.10.019. Epub 2010 Nov 18. New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy Lee HY11,?Lee KS,?Ahn MJ,?Hwang HS,?Lee JW,?Park K,?Ahn JS,?Kim TS,?Yi CA,?Chung MJ.
    View PubMed
  • J Thorac?Imaging.?2011 May;26(2):106-18. doi: 10.1097/RTI.0b013e3181fbaa64. Ground-glass Opacity Nodules Histopathology, Imaging Evaluation, and Clinical Implications Lee HY11,?Lee KS.
    View PubMed
  • Korean J Radiol.?2010 Nov-Dec;11(6):618-26. doi: 10.3348/kjr.2010.11.6.618. Epub 2010 Oct 29. Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria Lee HY11,?Lee KS,?Hwang HS,?Lee JW,?Ahn MJ,?Park K,?Kim TS,?Yi CA,?Chung MJ.
    View PubMed
  • Ann Surg Oncol.?2010 Oct;17(10):2787-94. doi: 10.1245/s10434-010-1107-z. Epub 2010 May 12. Volume-Based Parameter of F-18-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications Lee HY11,?Hyun SH,?Lee KS,?Kim BT,?Kim J,?Shim YM,?Ahn MJ,?Kim TS,?Yi CA,?Chung MJ.
    View PubMed
  • Lung?Cancer.?2010 Jul;69(1):123-6. doi:?10.1016/j.lungcan.2010.04.022. Epub 2010 May 16. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: An observation for more than 10 years Min JH11,?Lee HY,?Lee KS,?Han J,?Park K,?Ahn MJ,?Lee SJ.
    View PubMed
  • J Korean Med Sci.?2009 Dec;24(6):1132-8. doi: 10.3346/jkms.2009.24.6.1132. Epub 2009 Nov 9. Diagnostic Efficacy of PET/CT Plus Brain MR Imaging for Detection of Extrathoracic Metastases in Patients with Lung Adenocarcinoma Lee HY11,?Lee KS,?Kim BT,?Cho YS,?Lee EJ,?Yi CA,?Chung MJ,?Kim TS,?Kwon OJ,?Kim H.
    View PubMed
  • Lung Cancer.?2009 Aug;65(2):170-5. doi: 10.1016/j.lungcan.2008.11.009. Epub 2008 Dec 27. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons Lee HY11,?Lee KS,?Han J,?Kim BT,?Cho YS,?Shim YM,?Kim J.
    View PubMed
  • Korean J Radiol.?2009 May-Jun;10(3):244-51. doi: 10.3348/kjr.2009.10.3.244. Epub 2009 Apr 22. Classification of Focal Prostatic Lesions on Transrectal Ultrasound (TRUS) and the Accuracy of TRUS to Diagnose Prostate Cancer Lee HY11,?Lee HJ,?Byun SS,?Lee SE,?Hong SK,?Kim SH.
    View PubMed